MB
RGNX icon

MPM BioImpact’s Regenxbio RGNX Stock Holding History

MPM BioImpact’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50,000
Closed -$525K – 52
2024
Q3 		$525K Sell
50,000
-507,076
-91% -$6.18M 0.08% 42
2024
Q2 		$6.52M Buy
557,076
+7,998
+1% +$124K 1.01% 33
2024
Q1 		$11.6M Hold
549,078
– – 1.86% 18
2023
Q4 		$9.86M Sell
549,078
-107,640
-16% -$1.9M 2.31% 15
2023
Q3 		$10.8M Hold
656,718
– – 2.89% 14
2023
Q2 		$13.1M Buy
656,718
+39,047
+6% +$752K 2.64% 13
2023
Q1 		$11.7M Sell
617,671
-3,701
-0.6% -$81.9K 3.03% 12
2022
Q4 		$14.1M Buy
621,372
+2,289
+0.4% +$51.7K 3.66% 10
2022
Q3 		$16.4M Buy
+619,083
New +$18.4M 3.88% 10

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return